Ultralife Corp
(ULBI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 311 | N/A | -22,036 | -19,299 | -2,793 |
| Depreciation Amortization | 737 | N/A | 2,805 | N/A | 1,032 |
| Accounts receivable | -3,496 | N/A | -721 | -1,623 | -1,729 |
| Other Working Capital | -1,330 | N/A | -839 | N/A | -1,288 |
| Other Operating Activity | 3,716 | 0 | 16,758 | 17,992 | 2,272 |
| Operating Cash Flow | $-62 | $N/A | $-4,033 | $-2,930 | $-2,506 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,359 | N/A | -885 | N/A | -177 |
| Purchase Of Investment | N/A | N/A | 1,117 | 1,117 | 1,117 |
| Sale Of Investment | N/A | N/A | 1,399 | 1,399 | 1,399 |
| Other Investing Activity | 0 | 0 | 0 | -792 | 0 |
| Investing Cash Flow | $-1,359 | $N/A | $1,631 | $1,724 | $2,339 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 623 | N/A | 600 | 600 | N/A |
| Debt Repayment | -200 | N/A | -813 | -506 | -256 |
| Common Stock Issued | 2 | N/A | 2,350 | 2,350 | N/A |
| Other Financing Activity | 117 | 0 | 395 | 0 | 0 |
| Financing Cash Flow | $542 | $N/A | $2,532 | $2,444 | $-256 |
| Exchange Rate Effect | -49 | N/A | 93 | 72 | 61 |
| Beginning Cash Position | 1,322 | N/A | 706 | 706 | 706 |
| End Cash Position | 394 | N/A | 929 | 2,016 | 344 |
| Net Cash Flow | $-928 | $N/A | $223 | $1,310 | $-362 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62 | N/A | -4,033 | -2,930 | -2,506 |
| Capital Expenditure | -1,359 | N/A | -893 | -792 | -177 |
| Free Cash Flow | -1,421 | 0 | -4,926 | -3,722 | -2,683 |